Ondine Biomedical Inc. (AIM:OBI)
London · Delayed Price · Currency is GBP · Price in GBX 14.90
0.00 (0.00%)
Jul 6, 2026, 4:35 PM GMT
Ondine Biomedical Company Description
Ondine Biomedical Inc., a life-sciences company, engages in the development of activated antimicrobial therapies for the prevention and treatment of infections in Canada and internationally.
Its primary product is Steriwave, a non-invasive, nurse-administered treatment that eliminates harmful bacteria, viruses, and fungi from the nose.
In addition, the company offers a pipeline of photodisinfection products for various indications, including chronic sinusitis, ventilator-associated pneumonia, burns and other indications.
Ondine Biomedical Inc. was incorporated in 1996 and is headquartered in Vancouver, Canada.
Ondine Biomedical Inc.
| Country | Canada |
| Founded | 1996 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 18 |
| CEO | Carolyn Cross |
Contact Details
Address: 1100 Melville Street Vancouver, BC V6E 4A6 Canada | |
| Phone | 604 669 0555 |
| Website | ondinebio.com |
Stock Details
| Ticker Symbol | OBI |
| Exchange | London Stock Exchange AIM |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| ISIN Number | CA68234M2058 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Carolyn Cross | Chief Executive Officer |
| Alan Thomas | Chief Financial Officer |